[Comparison between Gd-DTPA-enhanced MRI and USPIO-enhanced MRI in diagnosing benign and metastatic cervical lymph

Yan Feng1, Gui-xiang Zhang, Han Wang

  • 1Department of Radiology, The First Affiliated Hospital, Shanghai Jiaotong University, Shanghai 200080, China.

Abstract

Insights

Ultrasmall superparamagnetic iron oxide (USPIO)-enhanced MRI shows superior accuracy in identifying metastatic lymph nodes compared to gadolinium diethylenetriaminepenta-acetic acid (Gd-DTPA)-enhanced MRI in rabbit models.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Differentiating metastatic lymph nodes from reactive hyperplasia is crucial for cancer staging and treatment.
  • Gadolinium diethylenetriaminepenta-acetic acid (Gd-DTPA) and ultrasmall superparamagnetic iron oxide (USPIO) are contrast agents used in MRI.

Purpose of the Study:

  • To compare the diagnostic performance of Gd-DTPA-enhanced MRI and USPIO-enhanced MRI.
  • To evaluate their effectiveness in distinguishing reactive hyperplastic lymph nodes from metastatic lymph nodes in a rabbit model.

Main Methods:

  • Established reactive hyperplastic and tumor-bearing lymph node models in rabbits.
  • Acquired MRI images using both Gd-DTPA and USPIO contrast agents.
  • Correlated MRI findings with histopathological results.

Main Results:

  • USPIO-enhanced MRI demonstrated higher sensitivity (95.0%) and accuracy (92.9%) than Gd-DTPA-enhanced MRI (sensitivity 62.5%, accuracy 76.6%) in identifying metastatic lymph nodes.
  • USPIO-enhanced MRI also showed higher accuracy (87.1%) in the hyperplasia group compared to Gd-DTPA-enhanced MRI (74.2%).

Conclusions:

  • USPIO-enhanced MRI is more accurate than Gd-DTPA-enhanced MRI for diagnosing lymph node metastasis.
  • USPIO contrast offers improved diagnostic value in differentiating lymph node conditions.

Related Concept Videos